Riverside Law LLP
FIXaxFX bispecific antibody with common light chain
Bispecific antigen binding molecules (e.g., antibodies) that bind blood clotting factors, factor IXa (FIXa) and factor X (FX), and enhance the FIXa-catalysed activation of FX to FXa. Use of the bispecific antigen binding molecules to control bleeding, by replacing natural cofactor FVIIIa which is deficient in patients with haemophilia A.
KYMAB LIMITED
C C C C C C A C C C C
C07K C07K C07K C07K C07K C07K A61P C07K C07K C07K C07K
additional additional inventional additional additional additional inventional additional additional additional additional
Wei E-Chiang Roberto John Kenneth
Wang Lee Magliozzi Blackwood